 | • レポートコード：MRC23Q37549 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、87ページ • 納品方法：Eメール（2-3日） • 産業分類：消費財 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のヒト組換え増殖因子市場について調査・分析し、世界のヒト組換え増殖因子市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（組換えヒト上皮成長因子、その他）、用途別セグメント分析（科学研究、工業生産）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Thermo Fisher、Irvine Scientific、Biologics International Corp、R&D Systems、BioLegend、Corning、VWR、CellGenix GmbH、Shenandoah Biotechnologyなどが含まれています。 世界のヒト組換え増殖因子市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ヒト組換え増殖因子市場規模を推定する際に考慮しました。本レポートは、ヒト組換え増殖因子の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、ヒト組換え増殖因子に関するビジネス上の意思決定に役立てることを目的としています。 ・ヒト組換え増殖因子市場の概要 - 製品の定義 - ヒト組換え増殖因子のタイプ別セグメント - 世界のヒト組換え増殖因子市場規模：タイプ別分析（組換えヒト上皮成長因子、その他） - ヒト組換え増殖因子の用途別セグメント - 世界のヒト組換え増殖因子市場規模：用途別分析（科学研究、工業生産） - 世界のヒト組換え増殖因子市場規模予測（2018年-2029年） - ヒト組換え増殖因子の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - ヒト組換え増殖因子市場の競争状況およびトレンド ・ヒト組換え増殖因子の地域別市場規模 - 北米のヒト組換え増殖因子市場規模（2018年-2029年） - アメリカのヒト組換え増殖因子市場規模（2018年-2029年） - ヨーロッパのヒト組換え増殖因子市場規模（2018年-2029年） - アジア太平洋のヒト組換え増殖因子市場規模（2018年-2029年） - 中国のヒト組換え増殖因子市場規模（2018年-2029年） - 日本のヒト組換え増殖因子市場規模（2018年-2029年） - 韓国のヒト組換え増殖因子市場規模（2018年-2029年） - インドのヒト組換え増殖因子市場規模（2018年-2029年） - オーストラリアのヒト組換え増殖因子市場規模（2018年-2029年） - 中南米のヒト組換え増殖因子市場規模（2018年-2029年） - 中東・アフリカのヒト組換え増殖因子市場規模（2018年-2029年） ・タイプ別セグメント：組換えヒト上皮成長因子、その他 - 世界のヒト組換え増殖因子のタイプ別販売量（2018年-2023年） - 世界のヒト組換え増殖因子のタイプ別売上（2018年-2023年） - 世界のヒト組換え増殖因子のタイプ別価格 ・用途別セグメント：科学研究、工業生産 - 世界のヒト組換え増殖因子の用途別販売量（2018年-2023年） - 世界のヒト組換え増殖因子の用途別売上（2018年-2023年） - 世界のヒト組換え増殖因子の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Thermo Fisher、Irvine Scientific、Biologics International Corp、R&D Systems、BioLegend、Corning、VWR、CellGenix GmbH、Shenandoah Biotechnology ・産業チェーンと販売チャネルの分析 - ヒト組換え増殖因子産業チェーン分析 - ヒト組換え増殖因子の主要原材料 - ヒト組換え増殖因子の販売チャネル - ヒト組換え増殖因子のディストリビューター - ヒト組換え増殖因子の主要顧客 ・ヒト組換え増殖因子市場ダイナミクス - ヒト組換え増殖因子の業界動向 - ヒト組換え増殖因子市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Human Recombinant Growth Factors market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Human Recombinant Growth Factors is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Human Recombinant Growth Factors is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Human Recombinant Growth Factors include Thermo Fisher, Irvine Scientific, Biologics International Corp, R&D Systems, BioLegend, Corning, VWR, CellGenix GmbH and Shenandoah Biotechnology, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Recombinant Growth Factors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Recombinant Growth Factors.
The Human Recombinant Growth Factors market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Human Recombinant Growth Factors market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Recombinant Growth Factors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Thermo Fisher
Irvine Scientific
Biologics International Corp
R&D Systems
BioLegend
Corning
VWR
CellGenix GmbH
Shenandoah Biotechnology
Segment by Type
Recombinant Human Epidermal Growth Factor
Other
Segment by Application
Scientific Research
Industrial Production
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Recombinant Growth Factors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Recombinant Growth Factors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Human Recombinant Growth Factors Market Overview
1.1 Product Overview and Scope of Human Recombinant Growth Factors
1.2 Human Recombinant Growth Factors Segment by Type
1.2.1 Global Human Recombinant Growth Factors Market Value Comparison by Type (2023-2029)
1.2.2 Recombinant Human Epidermal Growth Factor
1.2.3 Other
1.3 Human Recombinant Growth Factors Segment by Application
1.3.1 Global Human Recombinant Growth Factors Market Value by Application: (2023-2029)
1.3.2 Scientific Research
1.3.3 Industrial Production
1.4 Global Human Recombinant Growth Factors Market Size Estimates and Forecasts
1.4.1 Global Human Recombinant Growth Factors Revenue 2018-2029
1.4.2 Global Human Recombinant Growth Factors Sales 2018-2029
1.4.3 Global Human Recombinant Growth Factors Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Human Recombinant Growth Factors Market Competition by Manufacturers
2.1 Global Human Recombinant Growth Factors Sales Market Share by Manufacturers (2018-2023)
2.2 Global Human Recombinant Growth Factors Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Human Recombinant Growth Factors Average Price by Manufacturers (2018-2023)
2.4 Global Human Recombinant Growth Factors Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Human Recombinant Growth Factors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Recombinant Growth Factors, Product Type & Application
2.7 Human Recombinant Growth Factors Market Competitive Situation and Trends
2.7.1 Human Recombinant Growth Factors Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Recombinant Growth Factors Players Market Share by Revenue
2.7.3 Global Human Recombinant Growth Factors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Recombinant Growth Factors Retrospective Market Scenario by Region
3.1 Global Human Recombinant Growth Factors Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Human Recombinant Growth Factors Global Human Recombinant Growth Factors Sales by Region: 2018-2029
3.2.1 Global Human Recombinant Growth Factors Sales by Region: 2018-2023
3.2.2 Global Human Recombinant Growth Factors Sales by Region: 2024-2029
3.3 Global Human Recombinant Growth Factors Global Human Recombinant Growth Factors Revenue by Region: 2018-2029
3.3.1 Global Human Recombinant Growth Factors Revenue by Region: 2018-2023
3.3.2 Global Human Recombinant Growth Factors Revenue by Region: 2024-2029
3.4 North America Human Recombinant Growth Factors Market Facts & Figures by Country
3.4.1 North America Human Recombinant Growth Factors Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Human Recombinant Growth Factors Sales by Country (2018-2029)
3.4.3 North America Human Recombinant Growth Factors Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Recombinant Growth Factors Market Facts & Figures by Country
3.5.1 Europe Human Recombinant Growth Factors Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Human Recombinant Growth Factors Sales by Country (2018-2029)
3.5.3 Europe Human Recombinant Growth Factors Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Recombinant Growth Factors Market Facts & Figures by Country
3.6.1 Asia Pacific Human Recombinant Growth Factors Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Human Recombinant Growth Factors Sales by Country (2018-2029)
3.6.3 Asia Pacific Human Recombinant Growth Factors Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Human Recombinant Growth Factors Market Facts & Figures by Country
3.7.1 Latin America Human Recombinant Growth Factors Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Human Recombinant Growth Factors Sales by Country (2018-2029)
3.7.3 Latin America Human Recombinant Growth Factors Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Recombinant Growth Factors Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Recombinant Growth Factors Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Human Recombinant Growth Factors Sales by Country (2018-2029)
3.8.3 Middle East and Africa Human Recombinant Growth Factors Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Recombinant Growth Factors Sales by Type (2018-2029)
4.1.1 Global Human Recombinant Growth Factors Sales by Type (2018-2023)
4.1.2 Global Human Recombinant Growth Factors Sales by Type (2024-2029)
4.1.3 Global Human Recombinant Growth Factors Sales Market Share by Type (2018-2029)
4.2 Global Human Recombinant Growth Factors Revenue by Type (2018-2029)
4.2.1 Global Human Recombinant Growth Factors Revenue by Type (2018-2023)
4.2.2 Global Human Recombinant Growth Factors Revenue by Type (2024-2029)
4.2.3 Global Human Recombinant Growth Factors Revenue Market Share by Type (2018-2029)
4.3 Global Human Recombinant Growth Factors Price by Type (2018-2029)
5 Segment by Application
5.1 Global Human Recombinant Growth Factors Sales by Application (2018-2029)
5.1.1 Global Human Recombinant Growth Factors Sales by Application (2018-2023)
5.1.2 Global Human Recombinant Growth Factors Sales by Application (2024-2029)
5.1.3 Global Human Recombinant Growth Factors Sales Market Share by Application (2018-2029)
5.2 Global Human Recombinant Growth Factors Revenue by Application (2018-2029)
5.2.1 Global Human Recombinant Growth Factors Revenue by Application (2018-2023)
5.2.2 Global Human Recombinant Growth Factors Revenue by Application (2024-2029)
5.2.3 Global Human Recombinant Growth Factors Revenue Market Share by Application (2018-2029)
5.3 Global Human Recombinant Growth Factors Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Thermo Fisher
6.1.1 Thermo Fisher Corporation Information
6.1.2 Thermo Fisher Description and Business Overview
6.1.3 Thermo Fisher Human Recombinant Growth Factors Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Thermo Fisher Human Recombinant Growth Factors Product Portfolio
6.1.5 Thermo Fisher Recent Developments/Updates
6.2 Irvine Scientific
6.2.1 Irvine Scientific Corporation Information
6.2.2 Irvine Scientific Description and Business Overview
6.2.3 Irvine Scientific Human Recombinant Growth Factors Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Irvine Scientific Human Recombinant Growth Factors Product Portfolio
6.2.5 Irvine Scientific Recent Developments/Updates
6.3 Biologics International Corp
6.3.1 Biologics International Corp Corporation Information
6.3.2 Biologics International Corp Description and Business Overview
6.3.3 Biologics International Corp Human Recombinant Growth Factors Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Biologics International Corp Human Recombinant Growth Factors Product Portfolio
6.3.5 Biologics International Corp Recent Developments/Updates
6.4 R&D Systems
6.4.1 R&D Systems Corporation Information
6.4.2 R&D Systems Description and Business Overview
6.4.3 R&D Systems Human Recombinant Growth Factors Sales, Revenue and Gross Margin (2018-2023)
6.4.4 R&D Systems Human Recombinant Growth Factors Product Portfolio
6.4.5 R&D Systems Recent Developments/Updates
6.5 BioLegend
6.5.1 BioLegend Corporation Information
6.5.2 BioLegend Description and Business Overview
6.5.3 BioLegend Human Recombinant Growth Factors Sales, Revenue and Gross Margin (2018-2023)
6.5.4 BioLegend Human Recombinant Growth Factors Product Portfolio
6.5.5 BioLegend Recent Developments/Updates
6.6 Corning
6.6.1 Corning Corporation Information
6.6.2 Corning Description and Business Overview
6.6.3 Corning Human Recombinant Growth Factors Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Corning Human Recombinant Growth Factors Product Portfolio
6.6.5 Corning Recent Developments/Updates
6.7 VWR
6.6.1 VWR Corporation Information
6.6.2 VWR Description and Business Overview
6.6.3 VWR Human Recombinant Growth Factors Sales, Revenue and Gross Margin (2018-2023)
6.4.4 VWR Human Recombinant Growth Factors Product Portfolio
6.7.5 VWR Recent Developments/Updates
6.8 CellGenix GmbH
6.8.1 CellGenix GmbH Corporation Information
6.8.2 CellGenix GmbH Description and Business Overview
6.8.3 CellGenix GmbH Human Recombinant Growth Factors Sales, Revenue and Gross Margin (2018-2023)
6.8.4 CellGenix GmbH Human Recombinant Growth Factors Product Portfolio
6.8.5 CellGenix GmbH Recent Developments/Updates
6.9 Shenandoah Biotechnology
6.9.1 Shenandoah Biotechnology Corporation Information
6.9.2 Shenandoah Biotechnology Description and Business Overview
6.9.3 Shenandoah Biotechnology Human Recombinant Growth Factors Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Shenandoah Biotechnology Human Recombinant Growth Factors Product Portfolio
6.9.5 Shenandoah Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Recombinant Growth Factors Industry Chain Analysis
7.2 Human Recombinant Growth Factors Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Recombinant Growth Factors Production Mode & Process
7.4 Human Recombinant Growth Factors Sales and Marketing
7.4.1 Human Recombinant Growth Factors Sales Channels
7.4.2 Human Recombinant Growth Factors Distributors
7.5 Human Recombinant Growth Factors Customers
8 Human Recombinant Growth Factors Market Dynamics
8.1 Human Recombinant Growth Factors Industry Trends
8.2 Human Recombinant Growth Factors Market Drivers
8.3 Human Recombinant Growth Factors Market Challenges
8.4 Human Recombinant Growth Factors Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer